---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-000871"
form_type: "8-K"
ticker: "ADMA"
cik: "0001368514"
company_name: "ADMA BIOLOGICS, INC."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T02:59:00.611550+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# ADMA Biologics furnishes January 2025 corporate presentation without material updates

## Summary
- Corporate presentation furnished under Regulation FD; no specific financial results or guidance changes disclosed.
- Presentation expected to be used in meetings with investors, analysts, and strategic partners.
- Exhibit contains only a title slide; no operational or strategic updates provided.
- Company makes no admission as to materiality of information furnished.

## SEC filing metadata
- accession: 0001140361-25-000871
- form_type: 8-K
- ticker: ADMA
- cik: 0001368514
- company_name: ADMA BIOLOGICS, INC.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1368514/000114036125000871/0001140361-25-000871-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1368514/000114036125000871/ef20041449_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-000871
- JSON: https://secwatch.observer/filing/0001140361-25-000871.json
- Plain text: https://secwatch.observer/filing/0001140361-25-000871.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.